Notice2023-11928
Uniform Formulary Beneficiary Advisory Panel; Notice of Federal Advisory Committee Meeting
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
June 6, 2023
Issuing agencies
Defense Department
Abstract
The DoD is publishing this notice to announce that the following Federal Advisory Committee meeting of the Uniform Formulary Beneficiary Advisory Panel (UFBAP) will take place.
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 108 (Tuesday, June 6, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 108 (Tuesday, June 6, 2023)]
[Notices]
[Pages 37044-37045]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-11928]
-----------------------------------------------------------------------
DEPARTMENT OF DEFENSE
Office of the Secretary
Uniform Formulary Beneficiary Advisory Panel; Notice of Federal
Advisory Committee Meeting
AGENCY: Under Secretary of Defense for Personnel and Readiness,
Department of Defense (DoD).
ACTION: Notice of federal advisory committee meeting.
-----------------------------------------------------------------------
SUMMARY: The DoD is publishing this notice to announce that the
following Federal Advisory Committee meeting of the Uniform Formulary
Beneficiary Advisory Panel (UFBAP) will take place.
DATES: Open to the public Wednesday, June 28, 2023, 10:00 a.m.-1:00
p.m. (Eastern Standard Time).
ADDRESSES: The meeting will be held telephonically or via conference
call. The phone number for the remote access on June 28, 2023 is:
CONUS: 1-800-369-2046; OCONUS: 1-203-827-7030; Participant Code:
8546285.
These numbers and the dial-in instructions will also be posted on
the UFBAP website at: <a href="https://www.health.mil/Military-Health-Topics/Access-Cost-Quality-and-Safety/Pharmacy-Operations/BAP">https://www.health.mil/Military-Health-Topics/Access-Cost-Quality-and-Safety/Pharmacy-Operations/BAP</a>.
FOR FURTHER INFORMATION CONTACT: Designated Federal Official (DFO)
Colonel Paul B. Carby, USA, 703-681-2890 (voice), <a href="/cdn-cgi/l/email-protection#14707c753a7a77663a7e39223a79766c3a7675646671656171676067547c717578607c3a797d78"><span class="__cf_email__" data-cfemail="8febe7eea1e1ecfda1e5a2b9a1e2edf7a1edeefffdeafefaeafcfbfccfe7eaeee3fbe7a1e2e6e3">[email protected]</span></a> (email). Mailing address is 7700 Arlington
Boulevard, Suite 5101, Falls Church, VA 22042-5101. Website: <a href="https://www.health.mil/Military-Health-Topics/Access-Cost-Quality-and-Safety/Pharmacy-Operations/BAP">https://www.health.mil/Military-Health-Topics/Access-Cost-Quality-and-Safety/Pharmacy-Operations/BAP</a>. The most up-to-date changes to the meeting
agenda can be found on the website.
SUPPLEMENTARY INFORMATION: This meeting is being held under the
provisions of chapter 10 of the United States Code (U.S.C.) (commonly
known as the Federal Advisory Committee Act or FACA), the Government in
the Sunshine Act of 1976 (5 U.S.C. 552b, as amended), and 41 CFR 102-
3.140.
Purpose of the Meeting: The Panel will review and comment on
recommendations made to the Director, Defense Health Agency, by the
Pharmacy and Therapeutics Committee, regarding the Uniform Formulary.
Agenda
1. 10:00 a.m.-10:10 a.m. Sign in for UFBAP members
2. 10:10 a.m.-10:40 a.m. Welcome and Opening Remarks
a. Welcome, Opening Remarks, and Introduction of UFBAP Members by
DFO, UFBAP
b. Public Written Comments by DFO, UFBAP
c. Opening Remarks by UFBAP Co-Chair
d. Introductory Remarks by Chief, Formulary Management Branch
3. 10:40 a.m.-11:45 a.m. Scheduled Therapeutic Class Reviews
4. 1:45 a.m.-12:30 p.m. Newly Approved Drugs Review
5. 12:30 p.m.-12:45 p.m. Pertinent Utilization Management Issues
6. 12:45 p.m.-1:00 p.m. Closing Remarks
a. Closing Remarks by UFBAP Co-Chair
b. Closing Remarks by DFO, UFBAP
[[Page 37045]]
Meeting Accessibility: Pursuant to section 10(a)(1) of the FACA and
41 CFR 102-3.140 through 102-3.165, and subject to the availability of
phone lines, this meeting is open to the public. Telephone lines are
limited and available to the first 220 people dialing in. There will be
220 lines total: 200 domestic and 20 international, including leader
lines.
Written Statements: Pursuant to 41 CFR 102-3.140, and 3.150 and
section 10(a)(3) of FACA, interested persons or organizations may
submit written statements to the UFBAP about its mission and/or the
agenda to be addressed in this public meeting. Written statements
should be submitted to the UFBAP's DFO. The DFO's contact information
can be found in the FOR FURTHER INFORMATION CONTACT section of this
notice. Written comments or statements must be received by the UFBAP's
DFO at least five (5) calendar days prior to the meeting so they may be
made available to the UFBAP for its consideration prior to the meeting.
The DFO will review all submitted written statements and provide copies
to UFBAP.
Dated: May 31, 2023.
Aaron T. Siegel,
Alternate OSD Federal Register Liaison Officer, Department of Defense.
[FR Doc. 2023-11928 Filed 6-5-23; 8:45 am]
BILLING CODE 5001-06-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on June 6, 2023.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.